Skip to content
★ Sign in to follow
RC

RANGA c. KRISHNA

Executive
IGC Pharma, Inc.
Total declarations
14
Company
1
▲ Purchases (14 ops.)
€162k
▼ Sales (0 ops.)
—

Latest filing published 07 Sept 2012 for IGC Pharma, Inc., €8,073.

Insider track record

Disclosed buys
14
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
14
Positive at T+90
86%
Median T+90
+40.0%

Based on 14 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.

Purchases by company

Since each purchase

  • Filed 07 Sept 2012 · 5175 days ago · €8,073
    -51.5%
    Entry US$2.00 · Close at T+365 US$0.97
  • Filed 16 Jul 2012 · 5228 days ago · €7,640
    -34.3%
    Entry US$2.30 · Close at T+365 US$1.51
  • Filed 13 Jan 2012 · 5413 days ago · €15k
    -36.0%
    Entry US$2.50 · Close at T+365 US$1.60

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

RANGA c. KRISHNA: trading record in brief

All filings by RANGA c. KRISHNA on record concern IGC Pharma, Inc. In total, 14 filings cover trades dated from 10 August 2011 to 7 August 2012.

Every open-market trade on record is a purchase: 14 purchases worth €162k, and no sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. In 2012 alone, the filings show 14 purchases and no sales.

A typical purchase (the median) is worth €7,353. For 14 purchases whose 90-day window has closed, the share price was higher on day 90 than the day after publication in 86% of cases, with a median move of +40.0%. This is a record of the past, not a forecast.

On 7 September 2012 came the latest disclosure, an open-market purchase for €8,073 in IGC Pharma, Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to RANGA c. KRISHNA

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations14 total
  • ▲
    DirectorExecutivesIGC Pharma, Inc.
    10,000 USD0SEC
    50,000 shares@ US$0.20India Gloabalization IncSEC:0001509041-12-000005:0
    Canonical exit: 5 Nov 2012 (T+90)
  • ▲
    DirectorExecutivesIGC Pharma, Inc.
    9,315 USD0SEC
    40,500 shares@ US$0.23India GlobalizationSEC:0001509041-12-000004:0
    Canonical exit: 10 Oct 2012 (T+90)
  • ▲
    DirectorExecutivesIGC Pharma, Inc.
    115,000 USD0SEC
    500,000 shares@ US$0.23India Gloabalization CapSEC:0001509041-12-000003:0
    Canonical exit: 8 Nov 2011 (T+90)
  • ▲
    DirectorExecutivesIGC Pharma, Inc.
    20,000 USD0SEC
    100,000 shares@ US$0.20India Globalization CapSEC:0001509041-12-000003:1
    Canonical exit: 19 Dec 2011 (T+90)
  • ▲
    DirectorExecutivesIGC Pharma, Inc.
    12,692 USD0SEC
    66,800 shares@ US$0.19India Globalization CapSEC:0001509041-12-000003:2
    Canonical exit: 25 Dec 2011 (T+90)
  • ▲
    DirectorExecutivesIGC Pharma, Inc.
    5,700 USD0SEC
    30,000 shares@ US$0.19India Globalization CapSEC:0001509041-12-000003:3
    Canonical exit: 27 Dec 2011 (T+90)
  • ▲
    DirectorExecutivesIGC Pharma, Inc.
    4,009 USD0SEC
    21,100 shares@ US$0.19India Gloabalization CapSEC:0001509041-12-000003:4
    Canonical exit: 28 Dec 2011 (T+90)
  • ▲
    DirectorExecutivesIGC Pharma, Inc.
    14,122 USD0SEC
    78,456 shares@ US$0.18India Globalization CapSEC:0001509041-12-000003:5
    Canonical exit: 29 Dec 2011 (T+90)
  • ▲
    DirectorExecutivesIGC Pharma, Inc.
    9,324 USD0SEC
    51,799 shares@ US$0.18India Globalization CapSEC:0001509041-12-000003:6
    Canonical exit: 1 Jan 2012 (T+90)
  • ▲
    DirectorExecutivesIGC Pharma, Inc.
    850 USD0SEC
    5,000 shares@ US$0.17India Globalization CapSEC:0001509041-12-000003:7
    Canonical exit: 2 Jan 2012 (T+90)
  • ▲
    DirectorExecutivesIGC Pharma, Inc.
    10,540 USD0SEC
    62,000 shares@ US$0.17India Globalization CapSEC:0001509041-12-000003:8
    Canonical exit: 5 Jan 2012 (T+90)
  • ▲
    DirectorExecutivesIGC Pharma, Inc.
    5,103 USD0SEC
    30,020 shares@ US$0.17India Globalization CapSEC:0001509041-12-000003:9
    Canonical exit: 8 Jan 2012 (T+90)
  • ▲
    DirectorExecutivesIGC Pharma, Inc.
    3,400 USD0SEC
    20,000 shares@ US$0.17India Globalization CapSEC:0001509041-12-000003:10
    Canonical exit: 9 Jan 2012 (T+90)
  • ▲
    DirectorExecutivesIGC Pharma, Inc.
    2,121 USD0SEC
    11,786 shares@ US$0.18India Globalization CapSEC:0001509041-12-000003:11
    Canonical exit: 12 Jan 2012 (T+90)

14 of 14 declarations